Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. in the Healthcare sector is trading at $19.38 with a market capitalization of $223M. Wall Street consensus targets $88.00 (3 analysts), implying a +354.1% move over the next 12 months. The stock is currently 57% below its 52-week high of $45.50, remaining 6.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.